Regulation of gene expression in osteoblasts
- PMID: 20087883
- PMCID: PMC2820584
- DOI: 10.1002/biof.72
Regulation of gene expression in osteoblasts
Abstract
In recent years, much progress has been made in understanding the factors that regulate the gene expression program that underlies the induction, proliferation, differentiation, and maturation of osteoblasts. A large and growing number of transcription factors make important contributions to the precise control of osteoblast formation and function. It has become increasingly clear that these diverse transcription factors and the signals that regulate their activity cannot be viewed as discrete, separate signaling pathways. Rather, they form a highly interconnected, cooperative network that permits gene expression to be closely regulated. There has also been a substantial increase in our understanding of the mechanistic control of gene expression by cofactors such as acetyltransferases and histone deacetylases. The purpose of this review is to highlight recent progress in understanding the major transcription factors and epigenetic coregulators, including histone deacetylases and microRNAs, involved in osteoblastogenesis and the mechanisms that determine their functions as regulators of gene expression.
Figures

Similar articles
-
NFATc1 mediates HDAC-dependent transcriptional repression of osteocalcin expression during osteoblast differentiation.Bone. 2009 Sep;45(3):579-89. doi: 10.1016/j.bone.2009.05.009. Epub 2009 May 20. Bone. 2009. PMID: 19463978 Free PMC article.
-
Wnt/β-catenin pathway regulates bone morphogenetic protein (BMP2)-mediated differentiation of dental follicle cells.J Periodontal Res. 2012 Jun;47(3):309-19. doi: 10.1111/j.1600-0765.2011.01433.x. Epub 2011 Dec 11. J Periodontal Res. 2012. PMID: 22150562 Free PMC article.
-
Zfp521 controls bone mass by HDAC3-dependent attenuation of Runx2 activity.J Cell Biol. 2010 Dec 27;191(7):1271-83. doi: 10.1083/jcb.201009107. Epub 2010 Dec 20. J Cell Biol. 2010. PMID: 21173110 Free PMC article.
-
Turning down the system: counter-regulatory mechanisms in bone and adaptive immunity.Immunol Rev. 2005 Dec;208:66-79. doi: 10.1111/j.0105-2896.2005.00322.x. Immunol Rev. 2005. PMID: 16313341 Review.
-
The role of microRNAs in the osteogenic and chondrogenic differentiation of mesenchymal stem cells and bone pathologies.Theranostics. 2021 Apr 30;11(13):6573-6591. doi: 10.7150/thno.55664. eCollection 2021. Theranostics. 2021. PMID: 33995677 Free PMC article. Review.
Cited by
-
TCF3, a novel positive regulator of osteogenesis, plays a crucial role in miR-17 modulating the diverse effect of canonical Wnt signaling in different microenvironments.Cell Death Dis. 2013 Mar 14;4(3):e539. doi: 10.1038/cddis.2013.65. Cell Death Dis. 2013. PMID: 23492770 Free PMC article.
-
Modulating OPG and TGF-β1 mRNA expression via bioelectrical stimulation.Bone Rep. 2021 Oct 9;15:101141. doi: 10.1016/j.bonr.2021.101141. eCollection 2021 Dec. Bone Rep. 2021. PMID: 34692946 Free PMC article.
-
Evolution of the miR199-214 cluster and vertebrate skeletal development.RNA Biol. 2014;11(4):281-94. doi: 10.4161/rna.28141. Epub 2014 Feb 20. RNA Biol. 2014. PMID: 24643020 Free PMC article.
-
Isolation and culture of neonatal mouse calvarial osteoblasts.Methods Mol Biol. 2014;1130:295-305. doi: 10.1007/978-1-62703-989-5_22. Methods Mol Biol. 2014. PMID: 24482182 Free PMC article.
-
Histone deacetylase inhibitors reduce differentiating osteoblast-mediated protection of acute myeloid leukemia cells from cytarabine.Oncotarget. 2017 Oct 10;8(55):94569-94579. doi: 10.18632/oncotarget.21809. eCollection 2017 Nov 7. Oncotarget. 2017. PMID: 29212250 Free PMC article.
References
-
- Tapscott SJ. The circuitry of a master switch: Myod and the regulation of skeletal muscle gene transcription. Development. 2005;132:2685–2695. - PubMed
-
- Tontonoz P, Spiegelman BM. Fat and beyond: the diverse biology of PPARgamma. Annu Rev Biochem. 2008;77:289–312. - PubMed
-
- de Crombrugghe B, Lefebvre V, Behringer RR, Bi W, Murakami S, Huang W. Transcriptional mechanisms of chondrocyte differentiation. Matrix Biol. 2000;19:389–394. - PubMed
-
- Komori T, Yagi H, Nomura S, Yamaguchi A, Sasaki K, Deguchi K, Shimizu Y, Bronson RT, Gao YH, Inada M, Sato M, Okamoto R, Kitamura Y, Yoshiki S, Kishimoto T. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell. 1997;89:755–764. - PubMed
-
- Otto F, Thornell AP, Crompton T, Denzel A, Gilmour KC, Rosewell IR, Stamp GW, Beddington RS, Mundlos S, Olsen BR, Selby PB, Owen MJ. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell. 1997;89:765–771. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources